Form 4: CRA International CEO Paul Maleh Reports Changes in Beneficial Ownership
SEC Form 4
Paul Maleh, CEO of CRA International, reports transactions involving common stock and restricted stock units.
Summary
- On March 14, 2025, Paul Maleh, the President and CEO of CRA International, executed transactions involving the company's common stock and restricted stock units (RSUs).
- These transactions included the acquisition and disposition of common stock, as well as the granting and vesting of RSUs.
- The reported transactions changed Maleh's direct ownership of common stock to 144,382 shares.
- Maleh also holds nonqualified stock options to purchase 16,304 shares at $44.87 and 15,173 shares at $47.45.
- The RSUs vest at various dates in the future, with some vesting in installments.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Future Outlook
The document details future vesting dates for restricted stock units, indicating future potential share issuance.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is common for executives to receive stock options and restricted stock units as part of their compensation packages, aligning their interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock units.
- The vesting schedules for RSUs are typical, often spanning several years to incentivize long-term performance.
- Companies like Accenture, McKinsey, and Boston Consulting Group also utilize similar compensation structures for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the CEO's stock ownership.
- The vesting of RSUs could potentially dilute existing shareholders' equity over time.
Key Dates
| Date | Description |
|---|---|
| 12/18/2017 | Date of grant for nonqualified stock option with exercise price of $44.87, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 12/06/2018 | Date of grant for nonqualified stock option with exercise price of $47.45, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 12/18/2027 | Expiration date for nonqualified stock option with exercise price of $44.87. |
| 12/06/2028 | Expiration date for nonqualified stock option with exercise price of $47.45. |
| 03/14/2025 | Date of transactions involving common stock and restricted stock units. |
| 03/18/2025 | Date of signature by power of attorney. |
| 03/22/2025 | Vesting date for some of the Restricted Stock Units. |
| 04/11/2025 | First vesting date for some of the Restricted Stock Units. |
| 03/10/2026 | Vesting date for some of the Restricted Stock Units. |
| 04/11/2026 | First vesting date for some of the Restricted Stock Units. |
| 04/29/2025 | First vesting date for some of the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.